IMPACT: Improving Proactive Approaches for Cancer Survivors’ Mental Health Treatment
Quality of Life
Study evaluating a mobile app for depression in adults with likely incurable cancer and elevated depressive symptoms
Clinicaltrials.gov identifier:NCT06582784
Study Contact Information:
Jennifer Dahne, PhD
Phone: 843-876-2280
Email: [email protected]
Noelle Natale
Phone: 843-876-9457
Email: [email protected]
About the Study
The IMPACT study is testing Moodivate, a mobile app designed to help manage depression. The app encourages users to plan and take part in activities they enjoy or find meaningful and track how these activities affect their mood.
This Study is Open To:
People may be eligible for this study if they:
- Are 18 years of age or older
- Have cancer that is considered likely incurable
- Have elevated depressive symptoms
- Own a smartphone compatible with the Moodivate app (iOS or Android)
- Are willing to use a mobile app to help manage depressive symptoms
- Have an email address they check regularly or regular access to text messages so they can complete follow-up questionnaires
This Study is NOT Open To:
People may not be eligible for this study if they:
- Have current suicidal thoughts
- Have a previous diagnosis of dementia or major neurocognitive disorder
- Have memory or thinking difficulties that interfere with their ability to function independently
What the Study Involves
Participants will be randomly assigned to one of two groups.
Group 1: Moodivate mobile app
- Participants will receive a code to download the Moodivate app and will be asked to use it at least once a day. The app encourages users to identify activities that are meaningful or enjoyable, schedule activities, track daily activities, and record their mood.
Group 2: Educational materials
- Participants will receive educational materials about managing mood and will be encouraged to discuss any questions with their oncology care provider. They will not be instructed to use the Moodivate app as part of the study.
All participants will complete electronic questionnaires about depressive symptoms and their study experiences each week for 8 weeks, followed by a final assessment at week 12. Participation lasts approximately 12 weeks.
Study Contact Information:
Jennifer Dahne, PhD
Phone: 843-876-2280
Email: [email protected]
Noelle Natale
Phone: 843-876-9457
Email: [email protected]
Quality of Life
Study evaluating a mobile app for depression in adults with likely incurable cancer and elevated depressive symptoms
Clinicaltrials.gov identifier:NCT06582784
Study Contact Information:
Jennifer Dahne, PhD
Phone: 843-876-2280
Email: [email protected]
Noelle Natale
Phone: 843-876-9457
Email: [email protected]